1. Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high-throughput amplicon sequencing
- Author
-
Katja Schmitt, Klemens Ruprecht, Eckart Meese, Christina Backes, Jens Mayer, and Christin Richter
- Subjects
Adult ,Male ,Multiple Sclerosis ,Transcription, Genetic ,viruses ,Immunology ,Molecular Sequence Data ,Endogenous retrovirus ,Locus (genetics) ,Biology ,Microbiology ,Genome ,Transcription (biology) ,Virology ,Humans ,Aged ,Genetics ,Reporter gene ,Genome, Human ,Endogenous Retroviruses ,Brain ,High-Throughput Nucleotide Sequencing ,Middle Aged ,Molecular biology ,Long terminal repeat ,Reverse transcriptase ,Insect Science ,Case-Control Studies ,embryonic structures ,Pathogenesis and Immunity ,Human genome - Abstract
Human endogenous retroviruses (HERVs) of the HERV-W group comprise hundreds of loci in the human genome. Deregulated HERV-W expression and HERV-W locus ERVWE1 -encoded Syncytin-1 protein have been implicated in the pathogenesis of multiple sclerosis (MS). However, the actual transcription of HERV-W loci in the MS context has not been comprehensively analyzed. We investigated transcription of HERV-W in MS brain lesions and white matter brain tissue from healthy controls by employing next-generation amplicon sequencing of HERV-W env -specific reverse transcriptase (RT) PCR products, thus revealing transcribed HERV-W loci and the relative transcript levels of those loci. We identified more than 100 HERV-W loci that were transcribed in the human brain, with a limited number of loci being predominantly transcribed. Importantly, relative transcript levels of HERV-W loci were very similar between MS and healthy brain tissue samples, refuting deregulated transcription of HERV-W env in MS brain lesions, including the high-level-transcribed ERVWE1 locus encoding Syncytin-1. Quantitative RT-PCR likewise did not reveal differences in MS regarding HERV-W env general transcript or ERVWE1 - and ERVWE2 -specific transcript levels. However, we obtained evidence for interindividual differences in HERV-W transcript levels. Reporter gene assays indicated promoter activity of many HERV-W long terminal repeats (LTRs), including structurally incomplete LTRs. Our comprehensive analysis of HERV-W transcription in the human brain thus provides important information on the biology of HERV-W in MS lesions and normal human brain, implications for study design, and mechanisms by which HERV-W may (or may not) be involved in MS.
- Published
- 2013